Impact of Treatment of COVID-19 with Sotrovimab on Post-Acute COVID-19 Syndrome: An Analysis of National COVID Cohort Collaborative (N3C) Data

被引：0
|
作者：
Drysdale, Myriam [1 ]
Chang, Rose [2 ]
Guo, Tracy [2 ]
Gillespie, Iain A. [3 ]
Kalia, Sarah [2 ]
Duh, Mei Sheng [2 ]
Han, Jennifer [4 ]
Birch, Helen [1 ]
Sharpe, Catherine [1 ]
Liu, Daisy [2 ]
DerSarkissian, Maral [5 ]
Van Dyke, Melissa [4 ]
机构：
[1] GSK, Brentford, Middx, England
[2] Anal Grp Inc, Boston, MA USA
[3] GSK, Stevenage, Herts, England
[4] GSK, Collegeville, PA USA
[5] Anal Grp Inc, Los Angeles, CA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
480
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [21] CHARACTERISTICS OF SURVIVORS OF COVID-19 SEEN AT A POST-ACUTE COVID-19 SYNDROME CLINIC
    Garner, Orlando
    Narendra, Dharani Kumari
    Guntupalli, Kalpalatha
    CHEST, 2021, 160 (04) : 1141A - 1142A
  • [22] Sex differences in determinants of COVID-19 severe outcomes - findings from the National COVID Cohort Collaborative (N3C)
    Yoshida, Yilin
    Chu, San
    Fox, Sarah
    Zu, Yuanhao
    Lovre, Dragana
    Denson, Joshua L.
    Miele, Lucio
    Mauvais-Jarvis, Franck
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [23] Sex differences in determinants of COVID-19 severe outcomes – findings from the National COVID Cohort Collaborative (N3C)
    Yilin Yoshida
    San Chu
    Sarah Fox
    Yuanhao Zu
    Dragana Lovre
    Joshua L. Denson
    Lucio Miele
    Franck Mauvais-Jarvis
    BMC Infectious Diseases, 22
  • [24] Glycemic Control and Clinical Outcomes in US Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database
    Wong, Rachel
    Hall, Margaret
    Vaddavalli, Rohith
    Anand, Adit
    Arora, Neha
    Bramante, Carolyn T.
    Garcia, Victor
    Johnson, Steven
    Saltz, Mary
    Tronieri, Jena S.
    Yoo, Yun Jae
    Buse, John B.
    Saltz, Joel
    Miller, Joshua
    Moffitt, Richard
    DIABETES CARE, 2022, 45 (05) : 1099 - 1106
  • [25] Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National Covid Cohort Collaborative (N3C)
    Xiao, Xuya
    Alexander, G. Caleb
    Mehta, Hemalkumar B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 198 - 199
  • [26] Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C)
    Xiao, Xuya
    Alexander, G. Caleb
    Mehta, Hemalkumar B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (08)
  • [27] Association Between COVID-19 and Mortality in Hip Fracture Surgery in the National COVID Cohort Collaborative (N3C): A Retrospective Cohort Study
    Levitt, Eli B.
    Patch, David A.
    Mabry, Scott
    Terrero, Alfredo
    Jaeger, Byron
    Haendel, Melissa A.
    Chute, Christopher G.
    Quade, Jonathan H.
    Ponce, Brent
    Theiss, Steven
    Spitler, Clay A.
    Johnson, Joey P.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS, 2022, 6 (01):
  • [28] Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome
    Abdalla, Mohnad
    El-Arabey, Amr Ahmed
    Gai, Zhongtao
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [29] COVID-19 and Post-Acute COVID-19 Syndrome: From Pathophysiology to Novel Translational Applications
    Ambrosino, Pasquale
    Lanzillo, Anna
    Maniscalco, Mauro
    BIOMEDICINES, 2022, 10 (01)
  • [30] Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C)
    Sidky, Hythem C.
    Young, Jessica C. T.
    Girvin, Andrew T.
    Lee, Eileen
    Shao, Yu Raymond
    Hotaling, Nathan
    Michael, Sam J.
    Wilkins, Kenneth J.
    Setoguchi, Soko
    Funk, Michele Jonsson
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
12345